ClinicalTrials.Veeva

Menu
N

Napa Research LLC | Napa, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ritonavir
Nirmatrelvir
PF-07321332
SEL-212
Buntanetap
E2027
Lanifibranor
Methotrexate
Etoposide
Serplulimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of Serplulimab + chemothe...

Enrolling
Limited-Stage Small Cell Lung Cancer
Drug: carboplatin/cisplatin-etoposide
Drug: Placebo

The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD)...

Enrolling
DLBCL Germinal Center B-Cell Type
Waldenstrom Macroglobulinemia
Drug: SGR-1505

This is a randomized, open-label study of Serplulimab plus chemotherapy (Carboplatin-Etoposide) in comparison with Atezolizumab plus chemotherapy in...

Enrolling
Extensive Stage Small Cell Lung Cancer
Drug: Serplulimab + chemotherapy (carboplatin-etoposide)
Drug: Atezolizumab + chemotherapy (carboplatin-etoposide)

Trial sponsors

Pfizer logo
H
A
Amgen logo
A
Eisai logo
I
S
Sobi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems